No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs371161127 |
chr1:144681352-144681353 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs374254607 |
chr1:144681377-144681378 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs199881692 |
chr1:144681389-144681390 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs587668965 |
chr1:144681402-144681403 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs587703260 |
chr1:144681460-144681461 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs587773490 |
chr1:144681508-144681509 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs112805905 |
chr1:144681513-144681514 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs587656214 |
chr1:144681528-144681529 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs587725019 |
chr1:144681568-144681569 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs587600288 |
chr1:144681613-144681614 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs587656375 |
chr1:144681618-144681619 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs587707725 |
chr1:144681622-144681623 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs587610907 |
chr1:144681627-144681628 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs587667209 |
chr1:144681644-144681645 |
Weak transcription Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs71265228 |
chr1:144681653-144681654 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs71265227 |
chr1:144681687-144681688 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs587744931 |
chr1:144681701-144681702 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs641666 |
chr1:144681723-144681724 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs587601338 |
chr1:144681798-144681799 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs67467472 |
chr1:144681814-144681815 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs114098845 |
chr1:144681820-144681821 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs61805401 |
chr1:144681844-144681845 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs61805402 |
chr1:144681913-144681914 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs587663330 |
chr1:144681916-144681917 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs587743288 |
chr1:144681919-144681920 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs587610237 |
chr1:144681949-144681950 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs587692583 |
chr1:144681961-144681962 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs587723970 |
chr1:144681988-144681989 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs587644019 |
chr1:144681990-144681991 |
Weak transcription Flanking Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs587702980 |
chr1:144682072-144682073 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs138524629 |
chr1:144682096-144682097 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs67254729 |
chr1:144682110-144682111 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs67728364 |
chr1:144682113-144682114 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs148662694 |
chr1:144682161-144682162 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs587776032 |
chr1:144682190-144682191 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs587643826 |
chr1:144682220-144682221 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs587695480 |
chr1:144682222-144682223 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs587757412 |
chr1:144682228-144682229 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs587647424 |
chr1:144682242-144682243 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs587710810 |
chr1:144682351-144682352 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs587767749 |
chr1:144682366-144682367 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs587642729 |
chr1:144682442-144682443 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs587708423 |
chr1:144682455-144682456 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs587609339 |
chr1:144682458-144682459 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs587660879 |
chr1:144682494-144682495 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs71222073 |
chr1:144682536-144682537 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs587713734 |
chr1:144682548-144682549 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs143734847 |
chr1:144682709-144682710 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs146810223 |
chr1:144682852-144682853 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs587594486 |
chr1:144682874-144682875 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|